Healthy volunteers
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Caucasian 2) Written declaration of consent signed and available
Exclusion criteria
Exclusion criteria: 1) known diseases of the hematopoietic system (e.g. blood clotting disorders, vascular diseases, neoplasia of the hematopoietic system) 2) known diseases of the hematopoietic system in 1st degree relatives 3) medication taken within the last week (except oral contraceptives) 4) Blood donation in the last 8 weeks 5) Pregnancy and breastfeeding 6) Known infectious diseases (e.g. hepatitis, HIV) 7) Persons in an active dependent relationship with the study leaders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quantitative analysis of the concentration and distribution of endogenous substances (e.g. serotonin and acylcarnitine) in blood cells. | — |
Secondary
| Measure | Time frame |
|---|---|
| Examination of the influence of the investigated substances on the function of blood cells as well as recording the variability of expression and function of various membrane transporters in healthy volunteers and the identification of potential predictive biomarkers (in particular genetic, epigenetic and metabolic biomarkers). | — |
Countries
Germany
Contacts
Institut für Pharmakologie